z.kowalski
Submits third-party assay reports on material purchased directly. Based in Ghent.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
10
n=10
Annotations
0
n=0
Median purity submitted
99.19%
n=10
Suppliers covered
8
n=10
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042020 | TB-500 | AMB | AMB-2602-P5987 | Janoshik | 2026-Q3 | 99.53 | 4.66 | 96.8 | Buyer-sourced | 0 | PASS |
| AX-2026-041794 | SS-31 (Elamipretide) | ASY | ASY-{CAT}-2139 | Kestrel | 2026-Q2 | 99.93 | 5.96 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019681 | Semax | TFC | TFC-2505-H2637 | Janoshik | 2025-Q4 | 99.93 | 7.50 | 100.1 | Supplier-supplied | 0 | PASS |
| AX-2025-020111 | 5-Amino-1MQ | SWB | SWB-2507-E8786 | Janoshik | 2025-Q3 | 99.57 | 6.10 | 92.1 | Buyer-sourced | 1 | FAIL |
| AX-2025-020456 | Tirzepatide | KP | KP-2504-V5402 | Kestrel | 2025-Q3 | 98.39 | 4.63 | 89.3 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-019575 | Tirzepatide | TFC | TFC-2507-T1116 | PeptideMeter | 2025-Q3 | 97.92 | 3.98 | 98.1 | Supplier-supplied | 0 | PASS |
| AX-2025-018931 | Tirzepatide | TFS | TFS-{CAT}-9918 | Janoshik | 2025-Q2 | 97.34 | 5.07 | 88.7 | Buyer-sourced | 2 | MARGINAL |
| AX-2025-018618 | GHRP-6 | QYB | QYB-2504-H5023 | Janoshik | 2025-Q2 | 99.04 | 6.53 | — | Buyer-sourced | 0 | PASS |
| AX-2025-020092 | Tirzepatide | SWB | SWB-2505-R8575 | Janoshik | 2025-Q2 | 99.21 | 2.60 | 89.3 | Buyer-sourced | 2 | MARGINAL |
| AX-2024-004916 | GHRP-2 | GGPeps | GGPE-2406-F1736 | Medutest | 2024-Q4 | 99.17 | 5.96 | 93.2 | Buyer-sourced | 0 | PASS |